Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ: EXAS )

56.68 -0.42 (-0.74%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Amicus Therapeutics Stock Sees Improving Market Leadership; Earns 81 RS Rating
On Monday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, to 81, up from 74 a day earlier. 
Via Investor's Business Daily
ARKK: The Pros and Cons Of Buying Into Cathie's Best-Known ETF
If you're a believer in the progress of science and technology and feel strongly that our best days are still ahead, then a slice of ARKK could be tempting. 
Via MarketBeat
Topics ETFs Economy
Exposures Interest Rates
ETF Returns: Mid-Cap Winners And Losers
We performed a screening of mid-cap ETFs - defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest positive and negative returns on... 
Via Benzinga
Analysts Think This Soaring Cathie Wood Stock Has Peaked. Are They Right?
Is it a matter of time before Exact Sciences stock starts giving back some of its impressive gains this year? 
Via The Motley Fool
Analyst Ratings for Exact Sciences
Via Benzinga
Canaccord Genuity Maintains Buy Rating for Exact Sciences: Here's What You Need To Know
Via Benzinga
What 8 Analyst Ratings Have To Say About Exact Sciences
Via Benzinga
1 Unstoppable Growth Stock to Buy and Hold for 10 Years
This company is finding success in fighting one of the deadliest illnesses. 
Via The Motley Fool
Cathie Wood's Ark Outshines S&P 500, Nasdaq In H1: Here Are The Major Trades It Made
Via Benzinga
This Big Cathie Wood Stock Is Outperforming Even Tesla
DraftKings is the strongest performer among Ark Invest's major holdings. 
Via Investor's Business Daily
Cologuard's Improved Performance to Accelerate Growth, Analyst Raises Expectations
Tuesday, Exact Sciences Corp (NASDAQ: EXAS) announced topline results from the pivotal BLUE-C study, showing that next-generation  
Via Benzinga
Stock Market Pulls Back After Several Weeks Of Gains: Weekly Review
But the major indexes and leading stocks generally showed healthy action. 
Via Investor's Business Daily
Analysts Bullish On Exact Sciences' Advanced Cancer Screening
Exact Sciences sees a bump in stock price amid rising revenue and study results that show advancements to its flagship Cologuard colorectal screening product. 
Via MarketBeat
Exact Sciences Set To Dominate Emerging Precision Oncology Market: Analyst Applauds $18B Potential Market
Benchmark analyst Bruce D. 
Via Benzinga
2 Stocks to Invest $500 In and Hold For 10 Years
Both companies have outperformed the market over the past year. 
Via The Motley Fool
Exact Sciences Stock Is Trading Higher: What's Going On?
Exact Sciences Corp (NASDAQ: EXAS) shares are trading higher Wednesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for  
Via Benzinga
Why Exact Sciences Stock Is Moving Higher After Hours
Exact Sciences Corp (NASDAQ: EXAS) shares are rising in extended trading Tuesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for  
Via Benzinga
Why Exact Sciences Stock With 219% Growth Could Surge Again
The company is trying to top its own success in colon cancer screening. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Revolutionary Companies With Trillion-Dollar Potential
These are just a few of the trillion-dollar potential companies to put on your radar screen for the second half. 
Via InvestorPlace
This Analyst With 87% Accuracy Rate Sees Around 16% Upside In Home Depot - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
The S&P 500 settled higher on Friday, surpassing the 4,300 level for the first time since August. The index also recorded gains for four weeks in a row. 
Via Benzinga
Why Top 2% Stock Exact Sciences Is On An Eight-Month Hot Streak — And Nearing A Profit-Taking Zone
The colon cancer screening market is vast, and underserved. Exact Sciences wants to change that. 
Via Investor's Business Daily
Cathie Wood Is Buying the SEC Lawsuit Dip in Coinbase (COIN) Stock
Coinbase and the crypto industry at large is at war with regulators. But Cathie Wood is still buying shares of COIN stock. 
Via InvestorPlace
Cathie Wood Onto 'Next Thing' In AI After ARK's Nvidia Exit: What's On Her Radar?
Via Benzinga
3 High-Flying Cathie Wood Stocks That Are Up Over 50% This Year
Is it too late to buy these rebounding stocks? 
Via The Motley Fool
MarketBeat Week in Review – 5/15 - 5/19
Investors are battling stagflation as they wait for a recession, and the MarketBeat team continues to help you understand where to find opportunities 
Via MarketBeat
Topics Economy Electric Vehicles
Exposures Economy Electric Vehicles Interest Rates
3 AI Stocks That Famed Investor Cathie Wood Is Betting On
Exact Sciences will look to leverage AI to revolutionize its industry. Here are some other Cathie Wood AI stocks to consider too. 
Via InvestorPlace
Exact Sciences Serves Investors Exactly What They Wished For
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The 
Via MarketBeat
3 Personalized Medicine Stocks to Buy for Long-Time Returns
Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out. 
Via InvestorPlace
A Bull Market Is Coming: 1 Supercharged Growth Stock to Buy Hand Over Fist Before It Soars 164%, According to Wall Street
This stock has been crushed by macroeconomic headwinds but could rebound big time if analysts are right. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.